CClinicalTrials.gg
RecruitingNCT04647968TRACHUpdated Jul 23, 2024

Primary vs Secondary Closure of Tracheo-cutaneous Fistulas

An interventional study of Primary closure of tracheo-cutaneous fistula and Secondary closure of tracheo-cutaneous fistula in Tracheostomy Complication, Post Tracheostomy Complications and Tracheostomy, sponsored by Université de Sherbrooke. Recruiting at 1 site in Canada. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-07-23.

Sponsored by Université de Sherbrooke · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jan 2026, 9 months ago, but the record still lists the study as recruiting.
  • Started Jan 2021; still recruiting 5 years 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The mean of this study is to compare primary and secondary closure of tracheo-cutaneous fistulas and evaluate the differences in outcomes between both techniques.

Read the detailed description

In this study the investigators wish to recruit patients with a tracheotomy that has been installed for various reasons and that is ready for closure. The investigators intend to randomly allocate them a mean of closure, either primary or secondary. Once the fistula is closed, the investigators will follow them over a substantial period of time to compare outcomes of each mean of closing. Different questionnaires will be used to best evaluate a range of variables.

02

Conditions studied

  • Tracheostomy Complication
  • Post Tracheostomy Complications
  • Tracheostomy

Keywords

  • tracheostomy
  • tracheostomy closure
  • tracheocutaneous fistula
03

In context

Fistula

731 studies on the registry are indexed under Fistula; 103 are open to participants now.

This study's planned enrollment of 44 is below the median of 60 across 484 interventional studies indexed under Fistula.

Browse Fistula studies →

Lead sponsor

Université de Sherbrooke is the lead sponsor of 289 studies on the registry; 68 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Being covered by the RAMQ
  • Having a tracheostomy either percutaneous or surgical
  • Being ready for canula removal and closure of the fistula

Exclusion criteria

Exclusion Criteria:

  • Presenting a contraindication to primary tracheotomy closure (granuloma)
  • Unable to consent
  • Refusal to participate
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
44 participants (estimated)

Study arms

  • Other
    Primary closure of tracheo-cutaneous fistula

    This group will undergo a protocoled primary closure of their tracheotomy.

    Procedure: Primary closure of tracheo-cutaneous fistula

  • Other
    Secondary closure of tracheo-cutaneous fistula

    This group will undergo a protocoled secondary closure of their tracheotomy.

    Procedure: Secondary closure of tracheo-cutaneous fistula

Interventions

  • ProcedurePrimary closure of tracheo-cutaneous fistula

    This procedure will follow protocoled steps. It consists of a sutured closure of the tracheotomy following local anesthesia, done at bedside.

  • ProcedureSecondary closure of tracheo-cutaneous fistula

    This procedure will follow protocoled steps. It consists of removing the tracheotomy canula and applying ointment and an Elastoplast on the site, which will be changed regularly until full healing of the wound.

06

What researchers measure

Primary outcomes

  1. Patient satisfaction in regards to the scar (change)

    This outcome will evaluate patient satisfaction in regards to his tracheotomy scar following closure, measured with the Patient observer scar assesment scale (POSAS) validated questionnaire. A high score means a worse outcome.

    Time frame: 1 week, 1 month, 3 months, 6 months

Secondary outcomes

  1. Healing time

    This outcome will evaluate time until full closure of the wound using both methods of closure.

    Time frame: 6 months

  2. Respiratory complications

    The investigators wish to establish whether there is a difference in respiratory complications occurence between the two means of closure.

    Time frame: 6 months

  3. Self reported quality of life related to dysphonia (change)

    The goal of this outcome is to evaluate the self reported quality of life of patients following tracheotomy closed by either mean. The investigators are going to use the Voice Handicap Index (VHI-10) validated questionnaire to better assess this outcome. A high score means a worse outcome, the highest score being 40.

    Time frame: 1 week, 1 month, 3 months, 6 months

  4. Persisting fistula

    This outcome intends to evaluate the frequency of persisting fistula using either method of closure.

    Time frame: 6 months

  5. Self reported quality of life related to dysphagia (change)

    The goal of this outcome is to evaluate the self reported quality of life of patients following tracheotomy closed by either mean. We are going to use the EAT-10 validated questionnaire to better assess this outcome. A high score means a worse outcome, the highest score being 40.

    Time frame: 1 week, 1 month, 3 months, 6 months

  6. Self reported quality of life related to dyspnea (change)

    The goal of this outcome is to evaluate the self reported quality of life of patients following tracheotomy closed by either mean. This will be measure by the Dyspnea Index (DI) validated questionnaire but also with the follow-up history. The Dyspnea Index questionnaire has a maximum score of 40. A high score means a worse outcome.

    Time frame: 1 week, 1 month, 3 months, 6 months

07

Study locations

1 of 1 sites recruiting
  • Centre hospitalier universitaire de Sherbrooke
    Sherbrooke, Quebec J1G 2E8, Canada
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 23, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04647968
Lead sponsor
Université de Sherbrooke
Responsible party
Simon Brisebois (Assistant Professor - Division of Otolaryngology - Head & Neck Surgery, Université de Sherbrooke) — Principal investigator
First posted
Dec 1, 2020
Start date
Jan 12, 2021
Primary completion
Jan 2026 (estimated)
Completion
Jul 2026 (estimated)
Last update
Jul 23, 2024

Study contacts

Simon Brisebois, MD, MSC
Contact
simon.brisebois@usherbrooke.ca
8193461110 ext. 24947
Brigitte Routhier-Chevrier, MD
Contact
brigitte.routhier-chevrier@usherbrooke.ca
8193461110 ext. 24947
Simon Brisebois, MD, MSC
principal investigator · Université de Sherbrooke

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion